Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Silver Modified and Conventional Atraumatic Restorative Treatment Modalities

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Medically free children.~2. Clinical examination revealing at least one second primary molar with single surface active dentine carious lesions.~3. Children who agreed to participate and whose parents signed an informed consent.~4. Cooperative or potentially cooperative children according to Wright Classification~Exclusion Criteria:~1. Children who have known allergies to silver products.~2. Children with special health care needs or any medical conditions.~3. Children with designated molars having more than one third of their crown missing.~4. Children with designated molars showing signs of pulpal pathology such as spontaneous pain, presence of an abscess or sinus or mobility.~5. Children with designated molars having an existing restoration.~6. Children with designated molars having deep carious lesions with close proximity to the pulp.

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 9 Years
- Healthy Volunteers: t

Study Arms:
- SMART (Type: EXPERIMENTAL): Silver modified atraumatic restorative treatment group in which advantage Arrest Silver diamine Fluoride 38% (Elevate oral Care, USA ) will be applied to carious molars then teeth will be restored with GC Fuji IX GP® FAST FAST Packable Posterior Restorative glass ionomer fillings (GC corporation, Tokyo, Japan)
- Conventional ART (Type: ACTIVE_COMPARATOR): Conventional atraumatic restorative treatment group in which a sharp excavator will be used to remove caries from carious molars then teeth will be restored with GC Fuji IX GP® FAST FAST Packable Posterior Restorative glass ionomer fillings (GC corporation, Tokyo, Japan)

Based on this trial design, predict the completion outcome and termination type (if applicable).